Genprex, Inc. Gains 29.05%

Fri, May 31, 2024 at 07:20 PM
Genprex, Inc. Gains 29.05%

Genprex, Inc. (GNPX:NASDAQ) rocketted at $3.11, representing a gain of 29%. On Fri, May 31, 2024, GNPX:NASDAQ touched a New 2-Week High of $3.11. The stock appeared on our News Catalysts scanner on Thu, May 30, 2024 at 09:49 AM in the 'MISCELLANEOUS' category. From Fri, May 17, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days

The stock spiked on Fri, May 31, 2024 at $4.09 with a volume of 3M+.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.